top of page

Molnupiravir: a promising new treatment for COVID-19

Early studies show molnupiravir to be the first oral medication effective against SARS-CoV-2. Safe at therapeutic levels, its active intracellular form introduces lethal mutations in the virus but does not mutate host cell DNA. Developed at Emory University and marketed by Merck, it is most effective when given early in infection. Wikipedia offers an excellent new summary at . If further studies confirm the value of molnupiravir, this will be a valuable addition to the fight against COVID-19. However, the best course remains for all of us and our loved ones to get vaccinated, minimizing our chances to get infected or sick with COVID-19 in the first place.

10 views0 comments

Recent Posts

See All

Music and Mind

I just finished reading the new book (2024) "Music and Mind: Harnessing the Arts for Health and Wellness" edited by Renée Fleming, the famous opera singer. At 558 pages, it is a bit long on anecdotal


bottom of page